Contact Us
Strategic Partnership Proposal
xLM Continuous Intelligence & Calibre Scientific
Transforming GxP compliance through AI-driven innovation across 25+ life sciences companies in 175+ countries
Prepared For:epared for
Dr. Siddhartha Kadia, CEO, Calibre Scientific
Prepared by
Nagesh Nama
CEO, xLM Continuous Intelligence
Date
February 1, 2026
Key Resources
Executive Summary
This proposal outlines a strategic partnership between xLM Continuous Intelligence and Calibre Scientific to integrate AI-driven GxP compliance solutions across Calibre's portfolio of 25+ life sciences and diagnostics companies operating in 175+ countries.
Value Proposition: xLM's agentic AI platform suite—including cIV (Continuous Intelligent Validation), cTM, cEMS, and cPdM—can transform Calibre's operational efficiency while strengthening regulatory compliance across its diverse portfolio of companies in lab research, diagnostics, and biopharmaceutical sectors.
70-80% reduction
in validation cycle times (8 weeks → 1 week)
Up to 90% savings
in manual compliance effort
30-40% reduction
in engineering time spent on documentation
< 3-month ROI guarantee
on implementation
Background: Calibre Scientific
Company Overview
Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and consumables serving three key communities:
  • Laboratory research
  • Diagnostics
  • Biopharmaceutical manufacturing
Key Facts
  • Founded: 2016
  • Headquarters: Holland, Ohio (with offices in Los Angeles, CA and Washington)
  • CEO: Dr. Siddhartha Kadia (appointed January 2025)
  • Portfolio: 25+ specialized life sciences and diagnostics companies
  • Global Reach: 175+ countries
  • Growth Strategy: Aggressive M&A activity (12 acquisitions since January 2023)
Strategic Context
Calibre's Growth Trajectory
  • Recent CEO transition (January 2025) signals transformation phase
  • Aggressive acquisition strategy indicates integration challenges
  • Portfolio companies span diverse verticals requiring operational standardization
  • Global footprint creates complexity in maintaining consistent GxP compliance
  • Pressure to demonstrate synergies across 25+ portfolio companies
Industry Challenges Calibre Faces
  1. Operational Costs: 8% increase in Q1 2024, requiring 8% economic surcharge on 2025 orders
  1. Supply Chain Disruptions: Affecting 70% of companies in sector (2024)
  1. Integration Complexity: Harmonizing systems across acquired companies
  1. Regulatory Pressure: Maintaining GxP compliance across diverse operations
  1. Competitive Pressure: Larger pharmaceutical companies entering CDMO/CRO space
Background: xLM Continuous Intelligence
Company Overview
xLM Continuous Intelligence is an AI-powered platform company specializing in GxP compliance automation for pharmaceutical, biotech, and medtech industries.
Core Mission: Transform compliance bottlenecks into competitive advantages through validated, agentic AI solutions.
ContinuousOS™
Validated platform framework (21 CFR Part 11, Annex 11, FDA CSA compliant)
Quality Management System
Based on ISO 9001:2015, GAMP 5, ASTM E 2500
Partnership
IBM collaboration for cLCG (Continuous Life Cycle Governance)
Delivery Model
Managed services—applications delivered pre-validated
Product Suite
1. Continuous Intelligent Validation (cIV) 🎯 Flagship Product
Revolutionary AI-powered validation platform that automates the entire SDLC:
Capabilities
  • Agent-1: Auto-generates User Requirements Specifications (URS) from user manuals
  • Agent-2: Creates detailed test cases with full traceability matrix
  • Agent-3: Executes test protocols with complete audit trail and evidence capture
  • Auto-exploration: AI agents navigate System Under Test (SUT) autonomously
  • Knowledge Graph: Catalogs inputs for intelligent artifact generation
Compliance Features
  • 21 CFR Part 11 compliant audit trails
  • EMA Annex 11 alignment
  • Complete traceability from URS → Test Cases → Execution
  • PDF-format GxP-compliant Test Plan Execution (TPE) reports
  • Human-in-the-loop validation checkpoints
Business Impact
87.5%
Cycle Time Reduction
Validation cycle: 8 weeks → 1 week
90%
Manual Effort Reduction
Up to 90% savings in manual work
  • Test coverage: Enhanced with AI-driven scenario generation
  • False positives/negatives: Dramatically reduced through ML algorithms
2. Continuous Temperature Mapping (cTM)
AI-powered temperature validation for warehouses, cleanrooms, and storage facilities:
Technology
  • Calibrated RF dataloggers with wireless gateway connectivity
  • Cloud-based data processing with ML anomaly detection
  • Automated dashboard generation (Temporary Sensors, Fixed Sensors, Sensor Mapping)
  • Isolation Forests and Local Outlier Factor algorithms for anomaly detection
Value Delivery
  • Eliminates manual data logging and reporting
  • Real-time temperature monitoring and alerts
  • Predictive analytics for proactive intervention
  • GxP-compliant PDF reports for regulatory submission
3. Continuous Predictive Maintenance (cPdM)
ML-powered predictive maintenance using IoT sensors:
Technology Stack
  • Isolation Forests and LSTM (Long Short-Term Memory) networks
  • Reinforcement Learning (RL) for continuous improvement
  • Real-time vibration, temperature, and pressure monitoring
  • GxP-compliant dashboards with audit-ready documentation
Business Impact
  • Reduces unplanned downtime
  • Optimizes maintenance schedules
  • Extends equipment lifespan
  • Minimizes spare parts inventory costs
Additional Managed Applications
  • cIGA: Continuous Intelligent GxP Audits
  • cRPA: Continuous Robotic Process Automation
  • cDIPM: Continuous Data Integrity Posture Management
  • cDM: Continuous Document Management
  • cALM: Continuous Application Lifecycle Management
  • cSM: Continuous Service Management
  • cRM: Continuous Risk Management
  • cRMM: Continuous Remote Monitoring and Management
  • cMP: Continuous Mail Protection
  • cMTR: Continuous Managed Threat Response
  • ciTOM: Continuous IT/OT Operations and Management
Total Portfolio: 15+ managed applications (expanding)
Differentiation & Competitive Advantage
Agentic AI Architecture
Autonomous agents that own entire processes (not just assist)
Delivered Validated
All apps pre-validated, eliminating customer CSV burden
Continuous Model
Not point-in-time validation—continuous smoke/regression testing
Industry-Specific
Purpose-built for GxP environments (not generic AI tools)
Proven ROI
< 3-month payback guarantee with 70-80% cycle time reductions
Risk-Based Validation
Aligned with FDA's Computer Software Assurance (CSA) guidance
Regulatory Alignment
FDA Guidance
  • Computer Software Assurance (September 2025) - Risk-based approach
  • AI in Drug Manufacturing guidance - Process control and monitoring applications
  • 21 CFR Part 11 - Electronic records and signatures
International Standards
  • EMA Annex 11 (EU GMP)
  • MHRA (UK)
  • TGA (Australia)
  • ISO 9001:2015, GAMP 5, ASTM E 2500
Strategic Partnership Opportunity
Partnership Vision
"Embed xLM's AI-driven GxP platform as the standardized compliance infrastructure across Calibre Scientific's 25+ portfolio companies, creating a unified, intelligent, and continuously compliant operational ecosystem."
Strategic Alignment
Why This Partnership Makes Strategic Sense Now
For Calibre Scientific
01
New CEO Mandate
Dr. Kadia (appointed Jan 2025) likely has mandate to drive operational excellence and innovation—xLM directly supports both
02
Integration Imperative
12 acquisitions since Jan 2023 require rapid operational harmonization—xLM provides standardized platform
03
Cost Pressure
8% operational cost increase demands efficiency gains—xLM delivers immediate ROI
04
Competitive Differentiation
As larger pharma companies enter CDMO/diagnostics space, Calibre needs technology edge
05
Scalability
With 175-country footprint, Calibre needs cloud-based, globally accessible solutions
For xLM
01
Enterprise Anchor Client
Calibre's 25+ companies = multiple deployment opportunities, recurring revenue
02
Reference Customer
Respected CEO with board positions (ALS, Applied Technical Services) provides credibility
03
Market Validation
Success with diversified portfolio proves platform scalability
04
Network Effect
Dr. Kadia's connections (McKinsey alumni, multiple boards) open additional doors
05
Revenue Acceleration
Calibre's revenue and growth trajectory = strong financial partner
Proposed Partnership Structure
Phase 1: Pilot Implementation
Months 1-3
Phase 2: Portfolio Rollout
Months 4-12
Phase 3: Strategic Expansion
Year 2+
Phase 1: Pilot Implementation (Months 1-3)
Objective: Demonstrate ROI with 2-3 high-impact use cases across 1-2 Calibre portfolio companies
Recommended Pilot Applications
1
cIV (Continuous Intelligent Validation)
Select 1 portfolio company with active software validation burden
  • Target: Reduce validation cycle from 8 weeks to 1 week
  • Deliver: Complete URS, test cases, TPE with audit trail
  • Validate: Full 21 CFR Part 11 compliance
2
cTM (Continuous Temperature Mapping)
Select 1 company with warehouse/storage validation needs
  • Target: Automate temperature mapping studies
  • Deliver: Real-time monitoring with GxP-compliant reports
  • Validate: Anomaly detection accuracy
Deliverables
  • Custom AI Transformation Blueprint (5-day xLM sprint: $8,999, credited back upon full implementation)
  • ROI analysis with 12 and 36-month projections
  • Pilot implementation at 1-2 sites
  • Proof of ROI documentation
  • Scalability roadmap for portfolio-wide rollout

Investment: $8,999 audit fee (credited back) + pilot implementation (custom quote)
Success Metrics
< 3-month payback demonstrated
70-80% cycle time reduction achieved
Zero compliance findings in validation artifacts
Positive user feedback from pilot teams
Phase 2: Portfolio Rollout (Months 4-12)
Objective: Scale proven solutions across Calibre's 25+ portfolio companies
Deployment Strategy
Option A: Horizontal Rollout (by application)
  • Deploy cIV across all companies requiring software validation
  • Deploy cTM across all companies with temperature-controlled facilities
  • Deploy cPdM across manufacturing-heavy portfolio companies
Option B: Vertical Rollout (by company)
  • Implement full xLM suite at priority companies first
  • Use early adopters as internal champions
  • Roll out to additional companies in waves
Recommended Approach: Hybrid model
1
Wave 1
High-impact companies with urgent compliance needs (5-7 companies)
2
Wave 2
Mid-tier portfolio companies (8-12 companies)
3
Wave 3
Remaining portfolio and new acquisitions (ongoing)
Deployment Support
  • Dedicated xLM Customer Success Manager
  • Implementation team for each wave
  • Training and change management support
  • Quarterly Business Reviews (QBRs) with Calibre leadership
Phase 3: Strategic Expansion (Year 2+)
Objective: Deepen partnership and explore additional value creation
1. Joint Product Development
  • Co-develop industry-specific modules for diagnostics sector
  • Customize applications for Calibre's unique portfolio needs
  • White-label xLM platform for Calibre's customer offering
2. Market Positioning
  • Joint case studies and white papers
  • Speaking engagements at industry conferences (PDA, ISPE)
  • Press releases highlighting operational excellence
3. M&A Integration Advantage
  • Use xLM platform as standard for all future Calibre acquisitions
  • Accelerate integration timeline for new companies
  • Create competitive moat in acquisition evaluation (targets with modernized systems more attractive)
4. Revenue Sharing Model
  • Explore offering xLM solutions to Calibre's customers
  • Create downstream revenue opportunities
  • Position Calibre as technology-enabled solutions provider (not just products)
Commercial Framework
Pricing Models (Flexible Options)
1
Per-Application SaaS Subscription
  • Monthly/annual subscription per application (cIV, cTM, cPdM, etc.)
  • Per-user or per-site licensing
  • Includes: Platform access, continuous validation, updates, support
2
Enterprise Portfolio License
  • Flat annual fee for unlimited access across all Calibre companies
  • All applications included
  • Volume discount for 25+ company portfolio
3
Outcome-Based Pricing
  • Fee tied to validated cost savings (e.g., % of documented efficiency gains)
  • Risk-sharing model aligns incentives
  • Guarantees ROI accountability
4
Hybrid Managed Services
  • XLM operates as "Compliance-as-a-Service" provider
  • Fully managed applications with SLA guarantees
  • Blended team model (xLM + Calibre resources)

Recommendation: Start with Model 1 for pilot, transition to Model 2 (Enterprise License) post-Phase 1 with volume discount reflecting portfolio scale.
Investment Range (Indicative)
$50K
Pilot Phase (Low End)
2-3 applications, 1-2 sites
$150K
Pilot Phase (High End)
2-3 applications, 1-2 sites
$750K
Portfolio Rollout (Low End)
25 companies annually
$2.5M
Portfolio Rollout (High End)
25 companies annually (depending on application mix)
Estimated Annual Savings for Calibre
$3M - $10M+
Based on 70-80% cycle time reductions and labor savings
Net ROI
3:1 to 7:1
Return in Year 1
Terms & Conditions
Contract Length: Multi-year preferred (3-5 years) with:
  • Annual true-up based on portfolio changes (acquisitions/divestitures)
  • Escalation clauses tied to CPI or fixed % (2-3%)
  • Termination for convenience with 90-day notice
Performance Guarantees
  • < 3-month payback or fee credit
  • 99.5% platform uptime SLA
  • Quarterly Business Reviews with documented KPIs
IP & Data Rights
  • Calibre retains ownership of all data
  • XLM retains platform IP
  • Joint ownership of co-developed modules (negotiable)
Compliance & Audit
  • Right to audit xLM's QMS annually
  • XLM supports Calibre's regulatory inspections
  • Mutual confidentiality and data security requirements
Conclusion
The Opportunity
Calibre Scientific stands at a pivotal moment—new CEO, ambitious growth strategy, portfolio integration challenges, and rising cost pressures. XLM Continuous Intelligence offers a proven, AI-powered solution that directly addresses these challenges while positioning Calibre as a technology leader in the life sciences tools and diagnostics sector.
The Alignment
Dr. Siddhartha Kadia's background—from EAG's testing rigor to Life Technologies' scale to McKinsey's analytical discipline—makes him uniquely positioned to appreciate xLM's value proposition. This isn't a speculative "AI experiment"—it's a strategic imperative with quantifiable ROI and minimal risk.
The Ask
We're requesting a 60-minute meeting to explore whether this partnership makes sense for Calibre. If there's mutual interest, we'll invest the time in a deep-dive AI Sprint to build a custom business case. If the numbers work (and we're confident they will), we'll proceed with a low-risk pilot. If they don't, we part as friends.
The Vision
Imagine Calibre Scientific in 2027—25+ portfolio companies operating on a unified, AI-powered compliance platform, with validation cycle times 80% faster than competitors, engineers freed from documentation drudgery to focus on innovation, and a reputation as the most operationally excellent life sciences tools company in the market.
That's the future xLM can help build. Let's start the conversation.
Contact Information
xLM Continuous Intelligence
Nagesh Nama
Chief Executive Officer
Key Resources
This proposal is confidential and intended solely for Dr. Siddhartha Kadia and the Calibre Scientific leadership team. Unauthorized distribution is prohibited.
All financial projections and ROI estimates are based on typical xLM client results and industry benchmarks. Actual results may vary based on Calibre's specific operational context. XLM guarantees <3-month ROI payback; if not achieved, fee credits will be applied as contractually agreed.
xLM Continuous Intelligence reserves the right to update this proposal based on additional discovery and alignment discussions with Calibre Scientific.